Evidence map›Paper›PMID 37546912›Full record

ArticleResearch square2023

Illuminating T cell-dendritic cell interactions in vivo by FlAsHing antigens.

Munir Akkaya, Jafar Al Souz, Daniel Williams, Rahul Kamdar, Olena Kamenyeva, Juraj Kabat, Ethan M Shevach, Billur Akkaya

Open access · greenAbstract readPreprint
In one paragraph

Article in Research square, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Munir AkkayaDepartment of Internal Medicine, Division of Rheumatology and Immunology, The College of Medicine, The Ohio State University, Columbus, OH 43210, USA.
Jafar Al SouzNational Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Daniel WilliamsNational Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Rahul KamdarNational Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Olena KamenyevaNational Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Juraj KabatNational Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Ethan M ShevachNational Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Billur AkkayaDepartment of Neurology, The College of Medicine, The Ohio State University, Columbus, OH 43210, USA.ORCID 0000-0002-6808-3776
National Institutes of Health · US

Funding

Control of Autoimmunity by Regulatory T CellsZIAAI000224 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI SHEVACH, ETHAN · 2009 to 2025
$13.4M
Deciphering the specificity and molecular mechanisms of regulatory T cells using novel approachesDP2AI154451 · NIAID · OHIO STATE UNIVERSITY · PI Billur Akkaya · 2022 to 2026
$2.3M
Intramural NIH HHS ZIA AI000224NIAID NIH HHS DP2 AI154451
6 · The paper itself

Abstract

Delineating the complex network of interactions between antigen-specific T cells and antigen presenting cells (APCs) is crucial for effective precision therapies against cancer, chronic infections, and autoimmunity. However, the existing arsenal for examining antigen-specific T cell interactions is restricted to a select few antigen-T cell receptor pairs, with limited in situ utility. This lack of versatility is largely due to the disruptive effects of reagents on the immune synapse, which hinder real-time monitoring of antigen-specific interactions. To address this limitation, we have developed a novel and versatile immune monitoring strategy by adding a short cysteine-rich tag to antigenic peptides that emits fluorescence upon binding to thiol-reactive biarsenical hairpin compounds. Our findings demonstrate the specificity and durability of the novel antigen-targeting probes during dynamic immune monitoring in vitro and in vivo. This strategy opens new avenues for biological validation of T-cell receptors with newly identified epitopes by revealing the behavior of previously unrecognized antigen-receptor pairs, expanding our understanding of T cell responses.

Indexed as

antigendendritic celllive imagingMHCIIT cell

Identifiers

PMID37546912
PMCPMC10402196
OpenAlexW4385235772

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.